CrossrefInfokarte
Second-Line Treatment of Pancreatic Adenocarcinoma: Shedding Light on New Opportunities and Key Talking Points from Clinical Trials
Clinical and Experimental Gastroenterology · 2024-04 · Volume 17 · 121-134
DOI: 10.2147/ceg.s390655 ↗Abstract
Kein Abstract verfügbar.
EUVIMED